论文部分内容阅读
随着化学和药物制造行业的跨国公司通过自身的发展和有选择的兼并而日益接近生物技术研究的活动中心,生物技术现在正在进入一个关键的阶段。这一科学领域在其发展初期主要是靠科学家们的努力来推动其进步的,当时唯一的限制就是可行性的限制。现在市场的需求与成本的降低成了压倒一切的首要因素。至今为止生物技术的进展一直是十分迅速的,预计它在药物制造、农业和食品工业中的进展仍将保持这种大步前进的势头;但是,在化学工业中,由于石油价格的下降,人们预料生物技术的进展步伐将有所放慢。至于环境保护方面,生物技术的应用前景仍可能需要若干年的时间才能实现。
As transnational corporations in the chemical and pharmaceutical manufacturing industries move closer to the center of biotechnology research through their own development and selective mergers, biotechnology is now at a crucial stage. In the early days of its development, the field of science was mainly driven by the efforts of scientists, and the only limitation at that time was the limit of feasibility. Now the market demand and cost reduction has become the overriding factor. Progress in biotechnology has been very rapid so far, and it is expected that its progress in the pharmaceutical manufacturing, agriculture and food industries will continue to take this stride forward; however, in the chemical industry, as the price of oil drops, people The pace of progress in biotechnology is expected to slow down. As for the protection of the environment, the application prospect of biotechnology may still take several years to achieve.